Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.4828T>G | p.Cys1610Gly | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
TGC | Cys | GGC | Gly | T->G | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #23 | Disulfide bonds 1610-1622 (C1) | No | No |
At the mRNA level | On restriction map |
NA | New restriction site(s): Hae III, Sau96 I Lost restriction site(s): none |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
1 | 0.00 (pathogenous) | 100 (Pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
UKD01EDI F0011 I01 | Proband | Female | de novo | ? (29 years old) | U.K. |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
C-Aortic insufficiency |
O-Myopia |
O-Retinal detachment |
S-Arachnodactyly (M) |
S-Characteristic facial appearance |
S-Chest deformity (unspecified) |
S-Joint hypermobility (m) |
S-Joint limitations |
Reference ID | PubMed ID | Reference |
41 | 9338581 | Hayward C, Porteous ME, Brock DJ. "Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: report of 12 novel mutations". Hum Mutat 1997;10(4):280-9 . |